RANKL Triggers Treg-Mediated Immunoregulation in Inflammatory Osteolysis

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of dentistry research

• Publication date

  2018-03-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1177/0022034518759302PMID 29499125PMCID PMC6728554
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral Tolerance Induced by OVA Intake Ameliorates TNBS-Induced Colitis in Mice

  2017cited by this paper
• Co-administration of RANKL and CTLA4 Antibodies Enhances Lymphocyte-Mediated Antitumor Immunity in Mice

  2017cited by this paper
• Characterization of the Protective Role of Regulatory T Cells in Experimental Periapical Lesion Development and Their Chemoattraction Manipulation as a Therapeutic Tool.

  2016cited by this paper
• Increased generation of Foxp3+ regulatory T cells by manipulating antigen presentation in the thymus

  2016cited by this paper
• Depletion of regulatory T cells leads to an exacerbation of delayed-type hypersensitivity arthritis in C57BL/6 mice that can be counteracted by IL-17 blockade

  2016cited by this paper
• Systemic administration of RANKL overcomes the bottleneck of oral vaccine delivery through microfold cells in ileum.

  2016cited by this paper
• A Distinct Function of Regulatory T Cells in Tissue Protection.

  2015cited by this paper
• Osteoprotegerin-Mediated Homeostasis of Rank+ Thymic Epithelial Cells Does Not Limit Foxp3+ Regulatory T Cell Development

  2015cited by this paper
• How Long to Treat with Denosumab

  2015cited by this paper
• The Regulatory T Cell: Jack-Of-All-Trades.

  2015cited by this paper
• Inhibition of the TNF Family Cytokine RANKL Prevents Autoimmune Inflammation in the Central Nervous System.

  2015cited by this paper
• Mouse anti-RANKL antibody delays oral wound healing and increases TRAP-positive mononuclear cells in bone marrow

  2015cited by this paper
• Cervical (pre)neoplastic microenvironment promotes the emergence of tolerogenic dendritic cells via RANKL secretion

  2015cited by this paper
• IL‐4/CCL22/CCR4 Axis Controls Regulatory T‐Cell Migration That Suppresses Inflammatory Bone Loss in Murine Experimental Periodontitis

  2015cited by this paper
• Restoring Host-Microbe Homeostasis via Selective Chemoattraction of Tregs

  2014cited by this paper
• Mesenchymal stem cells as active prohealing and immunosuppressive agents in periapical environment: evidence from human and experimental periapical lesions.

  2014cited by this paper
• The immune system, bone and RANKL.

  2014cited by this paper
• tTregs, pTregs, and iTregs: similarities and differences

  2014cited by this paper
• Infliximab attenuates inflammatory osteolysis in a model of periodontitis in Wistar rats

  2014cited by this paper
• Imbalance of interleukin-17+ T-cell and Foxp3+ regulatory T-cell dynamics in rat periapical lesions.

  2014cited by this paper
• RANKL Inhibitors Induce Osteonecrosis of the Jaw in Mice With Periapical Disease

  2014cited by this paper
• Enhanced Immunoprotective Effects by Anti‐IL‐17 Antibody Translates to Improved Skeletal Parameters Under Estrogen Deficiency Compared With Anti‐RANKL and Anti‐TNF‐α Antibodies

  2014cited by this paper
• A new antiresorptive approach to the treatment of fragility fractures: long-term efficacy and safety of denosumab

  2013cited by this paper
• Delayed-type hypersensitivity models in mice.

  2013cited by this paper
• Mesenchymal stromal cells and regulatory T cells: the Yin and Yang of peripheral tolerance?

  2013cited by this paper
• RANKL-RANK interaction in immune regulatory systems.

  2012cited by this paper
• Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab

  2012cited by this paper
• Expression analysis of wound healing genes in human periapical granulomas of progressive and stable nature.

  2012cited by this paper
• Review of osteoimmunology and the host response in endodontic and periodontal lesions

  2011cited by this paper
• Oral tolerance

  2011cited by this paper
• Do RANKL inhibitors (denosumab) affect inflammation and immunity?

  2011cited by this paper
• Antibody to Receptor Activator of NF-κB Ligand Ameliorates T Cell-Mediated Periodontal Bone Resorption

  2010cited by this paper
• RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFα or anti-IL-1 therapies

  2009cited by this paper
• iNOS -derived Nitric Oxide Modulates Infection-stimulated Bone Loss

  2008cited by this paper
• Crosstalk between RANKL and Fas signaling in dendritic cells controls immune tolerance.

  2007cited by this paper
• RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis.

  2007cited by this paper
• The dual role of p55 tumour necrosis factor‐α receptor in Actinobacillus actinomycetemcomitans‐induced experimental periodontitis: host protection and tissue destruction

  2006cited by this paper
• Regulation of Mucosal Dendritic Cell Function by Receptor Activator of NF-κB (RANK)/RANK Ligand Interactions: Impact on Tolerance Induction

  2002cited by this paper
• The role of macrophages in the induction of murine immune response to Actinobacillus actinomycetemcomitans.

  2002cited by this paper
• Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells.

  2001cited by this paper
• Osteoprotegerin ligand: A common link between osteoclastogenesis, lymph node formation and lymphocyte development

  1999cited by this paper

• Thymically imprinted heterogeneity results in differential Treg induction and stability of effector identity.

  2025cites this paper
• Comparative safety and efficacy of bisphosphonates, denosumab, and parathyroid hormone analogs for osteoporosis following lung transplantation

  2025cites this paper
• Modern Strategies for Osteoporosis Therapy: Current Status and Prospects for Targeted Intervention

  2025cites this paper
• Musculoskeletal Diseases: Mechanisms and Therapeutic Advances

  2025cites this paper
• The heterogeneity of T cell infiltration in human periapical lesions

  2025cites this paper
• Role of OPG/RANKL/RANK/TLR4 signaling pathway in sepsis-associated acute kidney injury

  2024cites this paper
• Nlrp3 inflammasome drives regulatory T cell depletion to accelerate periapical bone erosion.

  2024cites this paper
• Regulatory T cells engineered with polyphenol-functionalized immunosuppressant nanocomplexes for rebuilding periodontal hard tissue under inflammation-challenged microenvironment.

  2024cites this paper
• B Cells at the Core: Immune Mechanisms and Therapeutic Potentials in Periapical Lesions.

  2024cites this paper
• Epithelial RANKL Limits Experimental Periodontitis via Langerhans Cells

  2024cites this paper
• The immune landscape in apical periodontitis: From mechanism to therapy.

  2024cites this paper
• Osteoimmunology: The Crosstalk between T Cells, B Cells, and Osteoclasts in Rheumatoid Arthritis

  2024cites this paper
• Multiple biomaterials for immediate implant placement tissue repair: Current status and future perspectives

  2024cites this paper
• TLR2 agonist prevents the progression of periapical lesions in mice by reducing osteoclast activity and regulating the frequency of Tregs.

  2024cites this paper
• The Role of Breast Cancer Cells in Bone Metastasis: Suitable Seeds for Nourishing Soil

  2024cites this paper
• Current comprehensive understanding of denosumab (the RANKL neutralizing antibody) in the treatment of bone metastasis of malignant tumors, including pharmacological mechanism and clinical trials

  2023cites this paper
• Medication-related osteonecrosis of the jaw (MRONJ): a review of pathogenesis hypothesis and therapy strategies

  2023cites this paper
• Denosumab and Zoledronic Acid Differently Affect Circulating Immune Subsets: A Possible Role in the Onset of MRONJ

  2023cites this paper
• Correlations between Immune Response and Etiopathogenic Factors of Medication-Related Osteonecrosis of the Jaw in Cancer Patients Treated with Zoledronic Acid

  2023cites this paper
• CD4 Phenotypes Are Associated with Reduced Expansion of Tumor-Infiltrating Lymphocytes in Melanoma Patients Treated with Adoptive Cell Therapy.

  2023cites this paper
• Immune Dysfunction in Medication-Related Osteonecrosis of the Jaw

  2023influential citation
• The Tryptophan and Kynurenine Pathway Involved in the Development of Immune-Related Diseases

  2023cites this paper
• Influence of antiresorptive/antiangiogenic therapy on the extension of experimentally induced peri-implantitis lesions

  2023cites this paper
• Mechanisms of bone remodeling and therapeutic strategies in chronic apical periodontitis

  2022cites this paper
• Macrophage Involvement in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Comprehensive, Short Review

  2022cites this paper
• Molecular Mechanisms Leading from Periodontal Disease to Cancer

  2022cites this paper
• Semaphorin 7A accelerates the inflammatory osteolysis of periapical lesions.

  2022cites this paper
• Osteoimmunology: The correlation between osteoclasts and the Th17/Treg balance in osteoporosis

  2022cites this paper
• Influence of Gestational Hormones on the Bacteria-Induced Cytokine Response in Periodontitis

  2021cites this paper
• A review of T cells in periapical lesions.

  2021cites this paper
• VISTA Blockade Aggravates Bone Loss in Experimental Murine Apical Periodontitis

  2021cites this paper
• Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis

  2021cites this paper
• Pharyngeal spreading of peri-implant infections under antiresorptive/antiangiogenic therapy

  2021cites this paper
• The Crossroads of Periodontitis and Oral Squamous Cell Carcinoma: Immune Implications and Tumor Promoting Capacities

  2021influential citation
• Effect of the Periapical "Inflammatory Plug" on Dental Pulp Regeneration: A Histologic In Vivo Study.

  2020cites this paper
• RANKL-Targeted Combination Therapy with Osteoprotegerin Variant Devoid of TRAIL Binding Exerts Biphasic Effects on Skeletal Remodeling and Antitumor Immunity

  2020cites this paper
• Effect of intercellular adhesion molecule 1 deficiency on the development of apical periodontitis.

  2020cites this paper
• Determinants of Periodontal/Periapical Lesion Stability and Progression

  2020cites this paper
• An update of knowledge on the regulatory role of Treg cells in apical periodontitis.

  2020cites this paper
• Prognostic role of PD-L1 and immune-related gene expression profiles in giant cell tumors of bone

  2020cites this paper
• Osteoimmunology of Oral and Maxillofacial Diseases: Translational Applications Based on Biological Mechanisms

  2019cites this paper
• Mucosal Immunity and the FOXO1 Transcription Factors

  2019cites this paper
• To P or not to P, is that the question? Rethinking experimental design and data analysis to improve biological significance beyond the statistical significance

  2019cites this paper
• Vasoactive Intestinal Peptide Immunoregulatory Role at the Periapex: Associative and Mechanistic Evidences from Human and Experimental Periapical Lesions.

  2019cites this paper
• Production of Soluble Receptor Activator of Nuclear Factor Kappa-Β Ligand and Osteoprotegerin by Apical Periodontitis Cells in Culture and Their Modulation by Cytokines

  2019cites this paper
• Inflammatory profile of chronic apical periodontitis: a literature review

  2018cites this paper
• TBX21‐1993T/C polymorphism association with Th1 and Th17 response at periapex and with periapical lesions development risk

  2018cites this paper